deltatrials
Unknown PHASE4 NCT00153699

Relationship Between Topiramate Use and Ocular Angle Status

Relationship Between Topiramate Use and Ocular Angle Status: A Prospective Pilot Study

Sponsor: Chinese University of Hong Kong

Interventions Topiramate
Updated 5 times since 2017 Last updated: Oct 30, 2007 Started: Sep 30, 2004 Completion: Jul 31, 2007

This PHASE4 trial investigates Glaucoma, Angle-Closure and is currently ongoing. Chinese University of Hong Kong leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 19 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chinese University of Hong Kong
  • Hong Kong Eye Hospital
Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .